Prospective study of indoleamine 2,3-dioxygenase activity by mesenchymal stem cell in acute GVHD treatment
Not Applicable
Recruiting
- Conditions
- acute graft-versus-host disease
- Registration Number
- JPRN-UMIN000053400
- Lead Sponsor
- Gifu municipal hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients with a history of previous administration of TEMCELL. (2) Patients who are not scheduled to receive TEMCELL at the dosage and administration according to the attached document. (3) Other patients who are judged to be unsuitable for the indication by the physician's judgment.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IDO activity at each measurement time point from the time of engraftment.
- Secondary Outcome Measures
Name Time Method